Ignite Creation Date:
2024-05-06 @ 7:08 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05909098
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-06-22
First Post:
2023-06-02
Brief Title:
Safety and Efficacy of Autologous NK Cell Adjuvant Therapy for RelapsedRefractory Non-Hodgkins B-cell Lymphoma
Sponsor:
Xiangyang No1 Peoples Hospital
Organization:
Xiangyang No1 Peoples Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| B-cell Lymphoma Refractory |
| NK Cell |
| B-cell Lymphoma Recurrent |
Keywords: